Fractional exhaled nitric oxide non-suppression in asthma by Couillard Castonguay, S

Biological therapies for asthma by Couillard Castonguay, S, Pavord, I

Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype OxfoRd Asthma attaCk risk scaLE (ORACLE) by Couillard Castonguay, S, Do, WI, Beasley, R, Hinks, T, Pavord, I

Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing by Couillard, S, Shrimanker, R, Lemaire-Paquette, S, Hynes, GM, Borg, C, Connolly, C, Thulborn, S, Moran, AM, Poole, S, Morgan, S, Powell, T, Pavord, I, Hinks, T, Couillard Castonguay, S